"Acrylamides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Colorless, odorless crystals that are used extensively in research laboratories for the preparation of polyacrylamide gels for electrophoresis and in organic synthesis, and polymerization. Some of its polymers are used in sewage and wastewater treatment, permanent press fabrics, and as soil conditioning agents.
| Descriptor ID |
D000178
|
| MeSH Number(s) |
D02.065.122 D02.241.081.069.094
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Acrylamides".
Below are MeSH descriptors whose meaning is more specific than "Acrylamides".
This graph shows the total number of publications written about "Acrylamides" by people in this website by year, and whether "Acrylamides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 4 | 5 | 9 |
| 2018 | 5 | 5 | 10 |
| 2019 | 2 | 1 | 3 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Acrylamides" by people in Profiles.
-
Combining High-Throughput Synthesis and High-Throughput Protein Crystallography for Accelerated Hit Identification. Angew Chem Int Ed Engl. 2021 08 09; 60(33):18231-18239.
-
Coronavirus Disease 2019 or Lung Cancer: What Should We Treat? J Thorac Oncol. 2020 07; 15(7):e105-e106.
-
Treatment and Outcome of a Patient With Lung Cancer Infected With Severe Acute Respiratory Syndrome Coronavirus-2. J Thorac Oncol. 2020 05; 15(5):e63-e64.
-
Application of Dually Activated Michael Acceptor to the Rational Design of Reversible Covalent Inhibitor for Enterovirus 71 3C Protease. J Med Chem. 2019 07 11; 62(13):6146-6162.
-
The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma. J Exp Clin Cancer Res. 2019 May 23; 38(1):219.
-
The brain's traffic problems. Science. 2019 Jan 18; 363(6424):221-223.
-
Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors. Nat Commun. 2018 11 07; 9(1):4655.
-
High-throughput sequencing reveals distinct genetic features and clinical implications of NSCLC with de novo and acquired EGFR T790M mutation. Lung Cancer. 2018 10; 124:205-210.
-
EGFR-TKI-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients With Non-Small Cell Lung Cancer. JAMA Oncol. 2018 08 01; 4(8):1112-1115.
-
CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3). J Clin Oncol. 2018 09 10; 36(26):2702-2709.